| Serial Number | 98166206 |
| Word Mark | UTRAP |
| Filing Date | Wednesday, September 6, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, August 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 25, 2024 |
| Goods and Services | Pharmaceutical products, namely, lipid nanoparticles, for treating respiratory diseases; Pharmaceutical preparations for treating respiratory diseases, namely, a lipid-enabled drug for binding to agents of interest in particular viruses, bacteria, free-circulating proteins in the body; Pharmaceutical agents for treating respiratory diseases in the nature of biological blocking agents in the form of lipid nanoparticles that facilitate the binding of viruses, bacteria, protein of interest in biological fluids; Pharmaceutical preparations for the treatment of diseases and disorders, namely, allergies, autoimmune diseases, cancer, cardiovascular diseases, genetic diseases, hematological diseases, infectious diseases, inflammatory diseases, metabolic diseases, neurological diseases, ocular diseases and respiratory diseases |
| Pseudo Mark | U TRAP |
| Goods and Services | Lipid nanoparticles for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing surface chemistry for attachment of any protein, peptide and molecule to bind proteins of interest for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, and metabolic disorders; Biochemical preparations for scientific medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders; Reagents for scientific research and medical research use; Chemical reagents for non-medical purposes; Diagnostic reagents for clinical or medical laboratory use; chemistry reagents for scientific research and medical research use; Reagents comprised of nanoparticles for scientific research and medical research use; Reagents comprised of capsids for scientific research and medical research use; Reagents, namely, lipid nanoparticles, for scientific research and medical research use |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 28, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 28, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | utR Biotech |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Winnipeg, MB R3T5J4 CA |
| Party Name | utR Biotech |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Winnipeg, MB R3T5J4 CA |
| Event Date | Event Description |
| Thursday, September 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, September 9, 2023 | NEW APPLICATION ENTERED |
| Wednesday, May 1, 2024 | ASSIGNED TO EXAMINER |
| Friday, May 3, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, May 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 3, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, May 3, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, May 13, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, May 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 16, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 5, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 25, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 25, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 20, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |